Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07405424 · ClinicalTrials.gov registry record · NA

Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia

A NA study of Leukemia, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT07405424: Recruiting NA study of Leukemia, sponsored by University of Chicago.

NCT07405424 is a NA study of Leukemia that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 70 participants, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07405424, a NA study of Leukemia, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or to receive study-specific guided spiritual sessions.

Primary Outcome

Study will compare the number of potential participants to those that enroll and complete 3 out of 4 study intervention sessions.

Conditions Studied

Leukemia

Interventions

  • BEHAVIORAL SCORE Intervention

Study Locations (1)

Illinois

  • UChicago Medicine Comprehensive Cancer Center - Chicago

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2026-06-20
Est. Completion 2028-06-16
Phase NA
University of Chicago

796 total trials

What NCT07405424 shows while recruiting

NCT07405424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which SCORE Intervention is the first listed.

NCT07405424 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT07405424 about?

NCT07405424 is a clinical study titled "Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia". This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or...

What is the current status of trial NCT07405424?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-06-20. Estimated completion is 2028-06-16.

What conditions does trial NCT07405424 study?

This clinical trial studies the following conditions: Leukemia.

What interventions are being tested in trial NCT07405424?

The interventions under investigation include: SCORE Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07405424?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07405424 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07405424's enrollment target sits among peer trials

70 87th of 233 higher than 145 of 233 other Leukemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07405424

Source: ClinicalTrials.gov NCT07405424, the US trial registry maintained by the National Library of Medicine. NCT07405424 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.